ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L

Published:2016-08 Issue:1 Volume:379 Page:154-160
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wang Ronghao,Lin Wanying,Lin Changyi,Li Lei,Sun Yin,Chang Chawnshang

Funder

NIH

George Whipple Professorship Endowment

Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. Cancer statistics, 2013;Siegel;CA Cancer J. Clin,2013

2. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant;Sun;J. Clin. Invest,2010

3. The androgen/androgen receptor axis in prostate cancer;Bluemn;Curr. Opin. Oncol,2012

4. Androgen receptor in prostate cancer;Heinlein;Endocr. Rev,2004

5. Androgen signaling and its interactions with other signaling pathways in prostate cancer;Kaarbo;Bioessays,2007

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current uses and resistance mechanisms of enzalutamide in prostate cancer treatment;Expert Review of Anticancer Therapy;2024-09-14

2. Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders;European Journal of Medicinal Chemistry;2024-02

3. Inhibition of N‐myristoyltransferase activity promotes androgen receptor degradation in prostate cancer;The Prostate;2023-10-31

4. Effects of curcumin and ursolic acid in prostate cancer: A systematic review;Urologia Journal;2023-09-30

5. Therapeutic potential and limitations of curcumin as antimetastatic agent;Biomedicine & Pharmacotherapy;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3